![]() |
| Photo credit: Unknown. |
Hope everyone is having a happy and restful Labor Day! Back to work tomorrow!
1. HELPING CHEMISTS FIND JOBS IN A TOUGH MARKET. 2. TOWARDS A QUANTITATIVE UNDERSTANDING OF THE QUALITY OF THE CHEMISTRY JOB MARKET.
| # of Industrial ads in C&EN issue with technical program or final program |
| Chart by Chemjobber. Photo credit: Thomas Klapoetke |
Q: So what is the prognosis on your hands so far?Jyllian Kemsley has outdone herself again with a great analysis of an incident at Texas Tech University, where a graduate student made 100 times the recommended amount of a highly explosive material, nickel hydrazine perchlorate. When it exploded, he was severely injured.
A: The right hand is pretty good. And the left hand is missing 3 fingers, but they say that's looking pretty good.
Q: How's your vision?
A: It's fine. It's certainly not as good as it was before. But it's certainly good enough to do everyday things. So I don't need to spot eagles from, uh... you know.
Q: Are you right or left handed?
A: I was left handed. I'll have to be right handed now.
-from the transcript of an interview of the Texas Tech lab explosion victim.
"The impending closure of GlaxoSmithKline (GSK) sites in the UK and Italy, and the announcement by Astra Zeneca of the closure of the Loughborough (Charnwood) site with the loss of 1200 R&D staff along with the loss of jobs at the Avonmouth manufacturing site mean that many scientists in process R&D in the UK are falling on hard times. At the same time, Pfizer has cut staff in Medicinal Chemistry and Process R&D at Sandwich, UK, after the merger with Wyeth and has reduced the number of manufacturing sites in Ireland and elsewhere. So in the UK, the three major companies carrying out medicinal chemistry and process R&D are all reducing staffing levels. Now, where do those out of work, or for that matter new recruits from universities, find jobs? I wish I knew the answer!... In the United States I am sure the situation is no better with many major multinationals announcing layoffs in the last year, and even the biotech sector is not immune to similar problems."His advice to his colleagues? Find a CRO position or a job with a private pharmaceutical concern that isn't affected by all the merger-mania and keep networking. Good advice, but (as he would likely admit) there's not a lot of positions there, especially in the Western half of the world.
"Almost every industrial chemist I know who has been laid off remains unemployed. I am in the biotech/pharma industry and know of hundreds of synthetic chemists who have lost their jobs as pharma/biotech/ag/chemical industry has moved jobs off shore/downsized and as biotech companies focused their little remaining money on clinical development.To me, Anon906p's comment really has two relevant parts: A) the industrial synthesis jobs aren't coming back and that B) retraining synthetic/medicinal chemists for material scientists is more-or-less impractical. I hate to say something so trite, but only time will tell. (I hope he's wrong.)
The real question is: what is the unemployment rate of industrial chemists who did medicinal, synthetic, and other laboratory-based organic chemistry work? If you were highly trained as a medicinal/synthetic or other organic specialty, you are not likely to move into green inorganic material science without going back to graduate school.
Unless I am missing something, I do not see our industrial jobs ever coming back, so a whole generation of organic chemists will be lost, thrown out like so much useless trash. The profession will wither away outside of academic departments."
I suspect that the career fair at the upcoming ACS Meeting in Boston will be a zoo, regardless of job speciality (Pharma, Environmental, QA/QC). As if Boston weren't already a competitive job market for organic chemists, every grad student or postdoc from "top-tier" groups will probably be scheming to get positions that are suited for those with just the right amount of industrial experience. Any thoughts on what would be an "ideal" candidate for an entry-level position in MedChem or Process?Academic readers will be familiar with the concept of the ever-rising "funding line" or "pay line" for grants submitted to NIH. What is the equivalent expectation for Big Pharma these days?
What's the job market like for chemists? Dude -- it's always bad.*
How bad is it? How the heck should I know? Quantifying the chemistry job market is what this blog is about. That, and helping chemists find jobs.
E-mail chemjobber with helpful tips, career questions or angry comments at chemjobber -at- gmail dotcom. All correspondence is kept confidential. (Didn't get an e-mail back? It's okay to try again.) Please address correspondence to [Salutation] "Chemjobber" or "CJ." Greetings of only "Hi" or "Hello" are undesired. Emails from faculty members are answered faster than those from departmental admins or HR staff.
Voicemail/SMS: (302) 313-6257
Twitter: @chemjobber
RSS feed here
(The Blogger spam filter gets hungry sometimes, and likes to eat comments. You can e-mail me, and sometimes I can get it to cough up your comment. I am always happy to try.)
(*For the literal-minded, this is a joke. Mostly.)